International randomized, double-blind, placebo-controlled, phase 3 study of linsitinib (OSI-906, L) in patients (pts) with locally advanced or metastatic adrenocortical carcinoma (ACC).

被引：1
|
作者：
Quinn, David I.
Baudin, Eric
Demeure, Michael J.
Fassnacht, Martin
Hammer, Gary D.
Poondru, Srinivasu
Fleege, Tanya
Rorig, Ramona
Berruti, Alfredo
机构：
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[2] Inst Gustave Roussy, Villejuif, France
[3] TGen, Phoenix, AZ USA
[4] Univ Hosp Wuerzburg, Dept Internal Med 1, Endocrine Unit, Wurzburg, Germany
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] APGD, Northbrook, IL USA
[7] Astellas Pharma Global Dev, Northbrook, IL USA
[8] Astellas Pharma, Northbrook, IL USA
[9] Univ Brescia, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Med Oncol, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.4507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4507
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Bo Hu
    Gang Li
    Xiaohong Li
    Shan Wu
    Tingmin Yu
    Xiang Li
    Hongru Zhao
    Zhihua Jia
    Junpeng Zhuang
    Shengyuan Yu
    The Journal of Headache and Pain, 2022, 23
  • [32] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06): : 439 - 448
  • [33] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [34] Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 185 - 186
  • [35] DURVALUMAB, IN COMBINATION WITH AND FOLLOWING CHEMORADIOTHERAPY, IN LOCALLY ADVANCED CERVICAL CANCER: RESULTS FROM THE PHASE 3 INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CALLA TRIAL
    Monk, Bradley
    Toita, Takafumi
    Wu, Xiaohua
    Carlos Limon, Juan
    Zhou, Qi
    Tarnawski, Rafal
    Mandai, Masaki
    Shapira-Frommer, Ronnie
    Mahantshetty, Umesh
    Estevez-Diz, Maria Del Pilar
    Ramirez Godinez, Francisco
    Varga, Szilvia
    Leiva Galvez, Manuel Humberto
    Lee, Jung-Yun
    Kreynina, Yulia
    Howells, Kathryn
    Wildsmith, Sophie
    Dry, Hannah
    Nunes, Ana
    Mayadev, Jyoti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A2 - A3
  • [36] Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients
    Kato, Jitsu
    Matsui, Norirnitsu
    Kakehi, Yoshihiro
    Murayama, Emiko
    Ohwada, Shoichi
    Sugihara, Masahiro
    PAIN, 2019, 160 (05) : 1175 - 1185
  • [37] A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
    Howard, Joanna
    Kuo, Kevin H. M.
    Oluyadi, Abdulafeez
    Shao, Hui
    Morris, Susan
    Zaidi, Ahmar U.
    Van Beers, Eduard J.
    Thien, Swee Lay
    BLOOD, 2021, 138
  • [38] Randomized, double-blind, placebo-controlled phase II study of AMG 386 in combination with cisplatin and capecitabine (CX) in patients (pts) with metastatic gastroesophageal adenocarcinoma.
    Eatock, M. M.
    Szanto, J.
    Tebbutt, N. C.
    Bampton, C. L.
    Strickland, A. H.
    Valladares Ayerbes, M.
    Nanayakkara, N.
    Sun, Y.
    Adewoye, A. H.
    Bodoky, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [39] THE APPROACH STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF VOLANESORSEN ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FCS
    Gaudet, Daniel
    Digenio, Andres
    Alexander, Veronica J.
    Arca, Marcello
    Jones, Alan F.
    Stroes, Erik
    Bergeron, Jean
    Civeira, Fernando
    Hemphill, Linda C.
    Blom, Dirk J.
    Flaim, Joann
    Hughes, Steven
    Geary, Richard
    Tsimikas, Sotirios
    Bruckert, Eric
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 14 - +
  • [40] A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression
    Tohen, M.
    McDonnell, D. P.
    Case, M.
    Kanba, S.
    Ha, K.
    Fang, Y.
    Katagiri, H.
    Gomez, J. C.
    BIPOLAR DISORDERS, 2011, 13 : 100 - 100
12345